Polymicrobial community-acquired pneumonia: An emerging entity

Catia Cillõniz, Rok Civljak, Antonello Nicolini, Antoni Torres

Producción científica: Artículo CientíficoArtículo de revisiónrevisión exhaustiva

26 Citas (Scopus)

Resumen

Polymicrobial aetiology in community-acquired pneumonia (CAP) is more common than previously recognized. This growing new entity can influence inflammation, host immunity and disease outcomes in CAP patients. However, the true incidence is complicated to determine and probably underestimated due mainly to many cases going undetected, particularly in the outpatient setting, as the diagnostic yield is restricted by the sensitivity of currently available microbiologic tests and the ability to get certain types of clinical specimens. The observed rate of polymicrobial cases may also lead to new antibiotic therapy considerations. In this review, we discuss the pathogenesis, microbial interactions in pneumonia, epidemiology, biomarkers and antibiotic therapy for polymicrobial CAP.

Idioma originalInglés estadounidense
Páginas (desde-hasta)65-75
-11
PublicaciónRespirology
Volumen21
N.º1
DOI
EstadoIndizado - 1 ene. 2016
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© 2015 Asian Pacific Society of Respirology.

Huella

Profundice en los temas de investigación de 'Polymicrobial community-acquired pneumonia: An emerging entity'. En conjunto forman una huella única.

Citar esto